(Press-News.org) DALLAS – Jan. 26, 2012 – Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors. The unique test could preclude the need for surgery in patients whose tumors are located in areas of the brain too dangerous to biopsy.
This new magnetic resonance spectroscopy (MRS) technique provides a definitive diagnosis of cancer based on imaging of a protein associated with a mutated gene found in 80 percent of low- and intermediate-grade gliomas. Presence of the mutation also means a better prognosis.
"To our knowledge, this is the only direct metabolic consequence of a genetic mutation in a cancer cell that can be identified through noninvasive imaging," said Dr. Elizabeth Maher, associate professor of internal medicine and neurology at UT Southwestern and senior author of the study, available online in Nature Medicine. "This is a major breakthrough for brain tumor patients."
UT Southwestern researchers developed the test by modifying the settings of a magnetic resonance imaging (MRI) scanner to track the protein's levels. The data acquisition and analysis procedure was developed by study lead author Dr. Changho Choi, associate professor of the Advanced Imaging Research Center (AIRC) and radiology. Previous research linked high levels of this protein to the mutation, and UT Southwestern researchers already had been working on MRS of gliomas to find tumor biomarkers.
"Our next step is to make this testing procedure widely available as part of routine MRIs for brain tumors. It doesn't require any injections or special equipment," said Dr. Maher, medical director of UT Southwestern's neuro-oncology program.
To substantiate the test as a diagnostic tool, biopsy samples from 30 glioma patients enrolled in the UT Southwestern clinical trial were analyzed; half had the mutation and expected high levels of the protein. MRS imaging of these patients had been done before surgery and predicted, with 100 percent accuracy, which patients had the mutation.
For Thomas Smith of Grand Prairie, the test helped determine the best time to begin chemotherapy. When an MRS scan showed a sharp rise in the 25-year-old's protein levels, this indicated to his health care team that his tumor was moving from dormancy to rapid growth.
"We treated him with chemotherapy and his protein levels came down," Dr. Maher said.
Before participating in the study, Mr. Smith had tumor removal surgery in 2007. Because part of the tumor could not be safely removed, however, he continued to suffer seizures and had other neurological problems. Since chemotherapy, his symptoms have diminished.
"I did six rounds of chemo, every six weeks," Mr. Smith said. "My seizures stopped and all my symptoms improved. I am only on anti-seizure medication now."
INFORMATION:
Other UT Southwestern researchers involved in the study included Sandeep Ganji, a doctorate student in radiological sciences; Dr. Ralph DeBerardinis, assistant professor of pediatrics and with the Eugene McDermott Center for Human Growth and Development; Dr. Kimmo Hatanpaa, associate professor of pathology; Dr. Dinesh Rakheja, assistant professor of pathology; Dr. Zoltan Kovacs, assistant professor in the AIRC; Drs. Xiao-Li Yang and Tomoyuki Mashimo, both senior research scientists in internal medicine; Dr. Jack Raisanen, professor of pathology; Dr. Isaac Marin-Valencia, resident in pediatrics; Dr. Juan Pascual, assistant professor of neurology and neurotherapeutics, pediatrics, and physiology; Dr. Christopher Madden, associate professor of neurological surgery; Dr. Bruce Mickey, professor of neurological surgery and otolaryngology-head and neck surgery, and radiation oncology; Dr. Craig Malloy, professor in the AIRC and of internal medicine and radiology; and Dr. Robert Bachoo, assistant professor in neurology and neurotherapeutics, and internal medicine.
The research was supported by grants from the National Institutes of Health, the Cancer Prevention and Research Institute of Texas and financial support from the Annette G. Strauss Center for Neuro-oncology at UT Southwestern.
This news release is available on our World Wide Web home page at
www.utsouthwestern.edu/home/news/index.html
To automatically receive news releases from UT Southwestern via email, subscribe at www.utsouthwestern.edu/receivenews
Dr. Elizabeth Maher -- http://www.utsouthwestern.edu/fis/faculty/80409/elizabeth-maher.html
Diagnostic brain tumor test could revolutionize care of patients
2012-01-30
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
"Depression and Soul Retrieval" on January 31 "Why Shamanism Now?" Radio Show with Christina Pratt
2012-01-30
Streaming live on the Co-Creator Radio Network (www.co-creatornetwork.com) on Tuesday, January 31, at 11 a.m. Pacific time/2 p.m. Eastern time, on her show "Why Shamanism Now?: A Practical Path to Authenticity," shaman and founder of the Last Mask Center for Shamanic Healing Christina Pratt tells listeners that we may be able to measure the ways in which depression alters our brain chemistry. However, that does not prove that brain chemistry causes depression. One problem with the brain chemistry explanation is that it does nothing to help us ferret out the root ...
Spark Events Expands Into New Industry
2012-01-30
Spark Events launched yet another industry last week - Day Spa's and Salons located throughout the Kansas City Metro Area. These high-end day spas have enjoyed premier status for many years, and are looking to continue their dominance by Spark Event's marketing expertise.
"The entire team is ecstatic about these campaigns, because the day spas have so much potential, and we've eagerly been anticipating the kick off," states Luke Combs, account executive of Spark Events, who was present at all client set-ups. "We market for clients all throughout the region, ...
Study pinpoints genetic variation that raises a risk linked to bisphosphonates
2012-01-30
New York, NY (January 26, 2012) — Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors. The discovery paves the way for a genetic screening test to determine who can safely take these drugs. The study appears in the online version of the journal The Oncologist.
Oral bisphosphonates are currently taken by some 3 million women in the United States for the prevention or treatment ...
Changing people's behavior: From reducing bullying to training scientists
2012-01-30
San Diego, January 26, 2012 - If you want to change how teenagers view bullying, go to the straight to the source of most school trends: the most connected crowd. According to new intervention research, targeting the most influential students in a school could be a key factor in reducing harassment and bullying.
These results are part of a group of studies that are being presented today at a social psychology conference in San Diego, CA, on new, sometimes small, ways to make meaningful impacts on people's lives. "This is an exciting time in the field of social psychology," ...
RiverEdge Dental Welcomes Dr. Andrea Mandelbaum to Keswick Office
2012-01-30
The staff of RiverEdge Dental are pleased to announce the addition of Dr. Andrea Mandelbaum to their practice.
Dr. Mandelbaum Smith studied at York University, where she earned an Honours degree with a major in Biology and a minor in Psychology. She then proceeded to obtain a , doctor of dental surgery, DDS degree from The University of Western Ontario in London. Dr. Mandelbaum chose her career path at the tender age of sixteen, at the urging of her own dentist. She currently resides in Maple with her husband and infant son. Dr. Mandelbaum brings a wealth of experience ...
Rice, UCSD scientists probe form, function of mysterious protein
2012-01-30
HOUSTON -- (Jan. 26, 2012) -- Like a magician employing sleight of hand, the protein mitoNEET -- a mysterious but important player in diabetes, cancer and aging -- draws the eye with a flurry of movement in one location while the subtle, more crucial action takes place somewhere else.
Using a combination of laboratory experiments and computer modeling, scientists from Rice University and the University of California, San Diego (UCSD) have deciphered part of mitoNEET's movements to get a better understanding of how it handles its potentially toxic payload of iron and sulfur. ...
Author Karl Vanghen Chosen As One Of '50 Great Writers You Should Be Reading'
2012-01-30
Karl Vanghen, author of 'My Enemy, My Beloved', has been named one of '50 Great Writers You Should Be Reading'. His honors came as a result of his appearance on The Authors Show. Vanghen was chosen from a field of hundreds of authors through a public voting process. 'My Enemy, My Beloved' is an historical fiction novel that explores the life of a German POW held on American soil.
"I wrote this book," stated Mr. Vanghen, "to reveal the life and times of German POW's and citizens swept up in World War Two. As a native Minnesotan, I, like many others, was ...
Immunological mechanisms of oncolytic adenoviral therapy
2012-01-30
Cancer is one of the most common causes of death in humans. The conventional cancer therapies include surgery, radiotherapy, chemotherapy, and targeting therapies, which are intended to directly destroy and eliminate tumor cells. These treatments often fail, resulting in tumor metastasis and recurrence. Therefore, there is a critical need for novel cancer therapies. In recent years, an increasing number of studies have revealed that immune responses play a critical role in conventional cancer therapies. Replication-selective oncolytic viruses are a rapidly expanding therapeutic ...
Never Order W-2 Red-ink Forms, Employers Can Now Print W-2 Forms On Plain Paper with EzW2 Software
2012-01-30
IRS requires that employers need to furnish each employee a completed Form W-2, Wage and Tax Statement before Jan 31, 2012 mailing deadline. For 2012 tax season, employers can cut cost on the expensive pre-printed W-2 tax forms. Payroll tax software provider, Halfpricesoft.com (http://www.halfpricesoft.com) released the new ezW2 software, which can print all the W-2 forms on plain paper. The laser substitute forms of W-2 copy A and W-3 printed by ezW2 are SSA approved.
Available from just $39 per installation, ezW2 software has remained at that affordable price since ...
Assessment of COPD exacerbation severity with the COPD Assessment Test
2012-01-30
Exacerbation severity in patients with chronic obstructive pulmonary disease (COPD) can be reliably assessed with the COPD Assessment Test™ (CAT), according to a new study from the UK.
"There is currently no widely accepted standardized method for assessing symptom severity at exacerbations in COPD patients," said Dr Alex J Mackay, MBBS, MRCP, clinical research fellow at the Academic Unit of Respiratory Medicine, University College London. "Incorporating CAT scores into the assessment of COPD patients may provide a standardized, objective method for assessing symptom ...